Pricing Log in Create free account

Lakefront Biotherapeutics - Sponsored ADR (LKFT) vs Mineralys Therapeutics, Inc. (MLYS)

Lakefront Biotherapeutics - Sponsored ADR and Mineralys Therapeutics, Inc. are both Biotechnology companies. Lakefront Biotherapeutics - Sponsored ADR and Mineralys Therapeutics, Inc. are of similar size ($2.0B and $1.9B). Mineralys Therapeutics, Inc. has the higher net margin (0.00% vs −6.81%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Lakefront Biotherapeutics - Sponsored ADR leads on 7 and Mineralys Therapeutics, Inc. on 4.

Valuation

Metric LKFT MLYS Biotechnology median
P/E n/m n/m 8.50
P/S 6.98 n/m 9.71
P/B 0.52 3.12 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.51 n/m 0.64
EV/Sales (2.23) n/m 9.21
Earnings yield (0.95%) (20.89%) (33.15%)
Free cash flow yield (30.29%) (8.07%) (25.50%)

Profitability

Metric LKFT MLYS Biotechnology median
Gross margin 89.75% — 65.16%
Operating margin (90.11%) 0.00% 0.00%
Net margin (6.81%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (80.88%) (56.36%)
Return on assets 0.00% (69.67%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LKFT MLYS Biotechnology median
Revenue growth (TTM) (52.22%) — 6.02%
EPS growth (last fiscal year) 355.37% 37.43% 30.26%
Revenue growth, 5-year CAGR 15.75% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LKFT MLYS Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 32.84 34.46 4.72
Net debt to EBITDA (8.53) 3.85 0.96

Dividend

Metric LKFT MLYS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LKFT MLYS Biotechnology median
Market cap 1.97b 1.91b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack